Literature DB >> 33616084

CNS critical periods: implications for dystonia and other neurodevelopmental disorders.

Jay Li1,2, Sumin Kim2, Samuel S Pappas3,4, William T Dauer3,4,5.   

Abstract

Critical periods are discrete developmental stages when the nervous system is especially sensitive to stimuli that facilitate circuit maturation. The distinctive landscapes assumed by the developing CNS create analogous periods of susceptibility to pathogenic insults and responsiveness to therapy. Here, we review critical periods in nervous system development and disease, with an emphasis on the neurodevelopmental disorder DYT1 dystonia. We highlight clinical and laboratory observations supporting the existence of a critical period during which the DYT1 mutation is uniquely harmful, and the implications for future therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33616084      PMCID: PMC7934928          DOI: 10.1172/jci.insight.142483

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  140 in total

1.  lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.

Authors:  J M Miwa; I Ibanez-Tallon; G W Crabtree; R Sánchez; A Sali; L W Role; N Heintz
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

2.  A molecular mechanism underlying the neural-specific defect in torsinA mutant mice.

Authors:  Connie E Kim; Alex Perez; Guy Perkins; Mark H Ellisman; William T Dauer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 3.  Critical period regulation.

Authors:  Takao K Hensch
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

4.  Regulation of Torsin ATPases by LAP1 and LULL1.

Authors:  Chenguang Zhao; Rebecca S H Brown; Anna R Chase; Markus R Eisele; Christian Schlieker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

5.  Monaural occlusion alters sound localization during a sensitive period in the barn owl.

Authors:  E I Knudsen; S D Esterly; P F Knudsen
Journal:  J Neurosci       Date:  1984-04       Impact factor: 6.167

6.  Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.

Authors:  Sara Silva-Santos; Geeske M van Woerden; Caroline F Bruinsma; Edwin Mientjes; Mehrnoush Aghadavoud Jolfaei; Ben Distel; Steven A Kushner; Ype Elgersma
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

7.  Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors.

Authors:  Marta Maltese; Giuseppina Martella; Graziella Madeo; Irene Fagiolo; Annalisa Tassone; Giulia Ponterio; Giuseppe Sciamanna; Pierre Burbaud; P Jeffrey Conn; Paola Bonsi; Antonio Pisani
Journal:  Mov Disord       Date:  2014-09-04       Impact factor: 10.338

8.  Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia.

Authors:  A Quartarone; F Morgante; A Sant'angelo; V Rizzo; S Bagnato; C Terranova; H R Siebner; A Berardelli; P Girlanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-18       Impact factor: 10.154

9.  Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia.

Authors:  Neil J Risch; Susan B Bressman; Geetha Senthil; Laurie J Ozelius
Journal:  Am J Hum Genet       Date:  2007-04-27       Impact factor: 11.025

10.  Proteolytic regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix metalloproteinase 9 deficient mice.

Authors:  Emily A Kelly; Amanda S Russo; Cory D Jackson; Cassandra E Lamantia; Ania K Majewska
Journal:  Front Cell Neurosci       Date:  2015-09-22       Impact factor: 5.505

View more
  3 in total

Review 1.  The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes.

Authors:  Alessio Di Fonzo; Alberto Albanese; Hyder A Jinnah
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

2.  A pathogenic DYT-THAP1 dystonia mutation causes hypomyelination and loss of YY1 binding.

Authors:  Dhananjay Yellajoshyula; Abigail E Rogers; Audrey J Kim; Sumin Kim; Samuel S Pappas; William T Dauer
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 5.121

3.  THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes.

Authors:  Dhananjay Yellajoshyula; Samuel S Pappas; Abigail E Rogers; Biswa Choudhury; Xylena Reed; Jinhui Ding; Mark R Cookson; Vikram G Shakkottai; Roman J Giger; William T Dauer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.